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Abstract
Background: A key challenge in systems biology is the reconstruction of an organism’s metabolic network from its
genome sequence. One strategy for addressing this problem is to predict which metabolic pathways, from a
reference database of known pathways, are present in the organism, based on the annotated genome of the
organism.
Results: To quantitatively validate methods for pathway prediction, we developed a large “gold standard” dataset
of 5,610 pathway instances known to be present or absent in curated metabolic pathway databases for six
organisms. We defined a collection of 123 pathway features, whose information content we evaluated with respect
to the gold standard. Feature data were used as input to an extensive collection of machine learning (ML)
methods, including naïve Bayes, decision trees, and logistic regression, together with feature selection and
ensemble methods. We compared the ML methods to the previous PathoLogic algorithm for pathway prediction
using the gold standard dataset. We found that ML-based prediction methods can match the performance of the
PathoLogic algorithm. PathoLogic achieved an accuracy of 91% and an F-measure of 0.786. The ML-based
prediction methods achieved accuracy as high as 91.2% and F-measure as high as 0.787. The ML-based methods
output a probability for each predicted pathway, whereas PathoLogic does not, which provides more information
to the user and facilitates filtering of predicted pathways.
Conclusions: ML methods for pathway prediction perform as well as existing methods, and have qualitative
advantages in terms of extensibility, tunability, and explainability. More advanced prediction methods and/or more
sophisticated input features may improve the performance of ML methods. However, pathway prediction
performance appears to be limited largely by the ability to correctly match enzymes to the reactions they catalyze
based on genome annotations.
Background
A key step toward understanding an organism’s metabo-
lism is the construction of a comprehensive model of
the network of metabolic reactions taking place in the
organism. Although a number of such models have been
constructed through painstaking literature-based manual
curation [1,2], such an approach obviously cannot scale
to hundreds of sequenced genomes. Therefore, methods
are needed for computational characterization of meta-
bolic networks.
That task can involve two subtasks. (1) The reactome
prediction problem: Given the annotated genome for an
organism, predict the set of metabolic reactions
catalyzed by the organism; that is, predict associations
between enzymes and the reactions they catalyze. (2)
The pathway prediction problem: Given the reactome of
an organism and its annotated genome, predict the set
of metabolic pathways present in the organism. In the
current work we take the reactome as predetermined by
other methods, and focus on developing improved path-
way prediction methods. Pathway prediction can involve
predicting pathways that were previously known in
other organisms, or predicting novel pathways that have
not been previously observed (pathway discovery). Our
methodology does the former, predicting pathways from
a curated reference database.
We have previously developed a method, called Patho-
Logic [3], for automatically constructing a Pathway/Gen-
ome Database (PGDB) describing the metabolic network
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any medium, provided the original work is properly cited.of an organism, meaning the metabolic reactions catalyzed
by enzymes in the organism and their organization into
pathways. Based on the assumption that experimentally
defined metabolic pathways are conserved between organ-
isms, PathoLogic uses the MetaCyc [4] reference pathway
database as a template for predicting the metabolic path-
ways of a newly sequenced organism. MetaCyc version
13.5 contains 1,400 experimentally characterized pathways
curated from the literature for all domains of life.
Prediction of metabolic pathways in addition to the
reaction network is important because pathways provide
a higher level of organization that facilitates human
comprehension of the network, and pathways suggest
reactions and enzymes that may be initially missing
from the model because of omissions in the genome
annotation [5]. Prediction of pathways is hard for three
reasons. (1) Errors and omissions in genome annotations
introduce noise into the primary source of evidence for
pathways, namely, the set of metabolic enzymes in the
genome. (2) Enzymes that catalyze “promiscuous” reac-
tions – reactions that participate in multiple pathways –
are ambiguous in supporting the presence of more than
one pathway. In the version of MetaCyc used for this
work, 4,558 reactions participate in pathways. Of these,
779 reactions (17%) appear in at least two pathways. (3)
Groups of variant pathways in MetaCyc (pathways that
carry out the same biological function) often share sev-
eral reactions, making it difficult to distinguish which
variant is present.
At the core of PathoLogic is an algorithm for predict-
ing which subset of pathways from MetaCyc is present
in the organism. The algorithm incorporates rules and
heuristics developed and tuned over several years, using
feedback from biologists to improve the accuracy of the
predictions.
However, the PathoLogic algorithm suffers from sev-
eral limitations, which we aim to address in this work.
(1) As MetaCyc grew in size, PathoLogic began to make
more false positive pathway predictions. (2) The logic of
the PathoLogic algorithm is hard-coded, with compli-
cated interactions between various rules, making the
algorithm difficult to maintain and extend. (3) PathoLo-
gic provides limited explanations to the user as to why a
particular pathway was included in, or excluded from,
its predictions. Better quality explanations are needed.
(4) The algorithm is limited to Boolean predictions and
only a coarse measure of prediction confidence is pro-
vided by the number of reactions in the pathway whose
enzymes are known in the organism. Thus, it is difficult
to filter the predictions with a probability cutoff.
Our goal, therefore, is to develop a pathway prediction
algorithm that is data-driven, transparent,a n dtunable.
By data-driven we mean that the parameters determin-
ing the interaction of various predictive features are
separate from the detailed logic of the predictor, and
can be trained and modified at will. By transparent we
mean that the evidence for or against a given pathway’s
presence can be presented to the user. By tunable,w e
mean that the algorithm provides a fine-grained mea-
sure of prediction confidence, such that by varying a
threshold at which a prediction is made, the user can
trade off sensitivity for specificity. To satisfy these goals,
we have carried out the following work. (1) To quantify
the performance of our new prediction algorithms, and
compare them to the existing methods, we constructed
a large pathway “gold standard” containing data on the
presence or absence of metabolic pathways in various
organisms. (2) We designed and implemented 123 fea-
tures for evaluation in the new prediction algorithms.
This set includes features used by PathoLogic, but con-
sists mostly of new features. (3) We applied several
commonly used machine learning (ML) algorithms to
the pathway prediction problem. The best resulting ML-
based algorithm achieved a small improvement over the
performance of PathoLogic.
Methods
Figure 1 provides an overview of the process of applying
ML methods to pathway prediction. We describe each
step in detail below.
Construction of a Gold Standard Pathway Collection
To train our machine learning algorithms and validate
them against existing methods (namely, PathoLogic), we
constructed a “gold standard” dataset containing known
information about which pathways are present and
absent in a variety of organisms. The full gold standard
dataset can be found in Additional file 1; here we
describe the content and construction of the dataset.
The gold standard dataset currently contains 5,610
entries that describe pathway presence and absence in
six organisms: Escherichia coli K-12 MG1655, Arabidop-
sis thaliana columbia, Saccharomyces cerevisiae S288c,
Mus musculus, Bos taurus,a n dSynechococcus elongatus
PCC 7942. The data are derived mainly from the corre-
sponding PGDBs for these organisms: EcoCyc [1] ver-
sion 13.0, AraCyc [6,7] version 4.5, YeastCyc [8] version
March 2009, MouseCyc [9] version 1.41, CattleCyc [10]
version 1.2, and SynelCyc version 1.13.5 (unpublished),
all of which have undergone significant manual curation.
Data from EcoCyc are entirely derived from manual lit-
erature curation. AraCyc and YeastCyc were built using
an older version of PathoLogic, but have undergone
extensive manual curation to remove false positive path-
way predictions and to introduce additional pathways
from the literature that were not present in MetaCyc.
MouseCyc, CattleCyc, and SynelCyc were built within
the past 1 to 2 years using PathoLogic and have under-
gone subsequent manual curation: MouseCyc by
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Page 2 of 14Figure 1 Procedure for applying machine learning methods to metabolic pathway prediction. Data from curated pathway/genome
databases (PGDBs) are gathered into a “gold standard” collection. Features are defined using biological knowledge, and their values are
computed for all pathways in the gold standard. The resulting dataset is split into training and test sets. Training data are used to perform
feature selection and parameter estimation for multiple predictor types. Test data are used to evaluate the predictors. The predictor which
performs best on the test set will be applied to data from newly sequenced and annotated genomes to perform metabolic network
reconstruction.
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Page 3 of 14curators at the Jackson Laboratory, CattleCyc at the
University of Illinois, and SynelCyc in our group at SRI
International.
Each element of the gold standard dataset is a triple of
the form (organism, pathway, is-present?), asserting that
a pathway (referring to a pathway object in MetaCyc) is
present in or absent from an organism, depending on
whether is-present? is “true” or “false”.T a b l e1s h o w s
the number of positive and negative instances for each
organism in the gold standard.
As noted, different methods were used to construct
the PGDBs for the organisms represented in the gold
standard, and these have undergone differing amounts
of curation. For this reason, different rules were used to
select examples from each organism to include in the
gold standard. Two rules, however, applied to all organ-
isms. First, we added as positive examples in the gold
standard for each organism O all pathways that have
been curated in MetaCyc as being present in O. That is,
MetaCyc explicitly records the organism(s) in which
each pathway was experimentally studied. Second, we
added as gold standard negative examples for O all
pathways P in MetaCyc such that none of the reactions
of P had identifiable enzymes in the most recent gen-
ome annotation for O.
For E. coli we added as positives all pathways present
in EcoCyc. We added as negatives all pathways not
annotated in MetaCyc to be present in any strain of
Escherichia coli. A similar approach was used for A.
thaliana. We added as positives all pathways in AraCyc
with noncomputational evidence (meaning the pathways
were supported by an experimental evidence code, or by
the evidence code “inferred by curator”). All pathways
not present in AraCyc and not annotated in MetaCyc to
any subspecies of A. thaliana were added to the nega-
tive set. Both EcoCyc and AraCyc have undergone
extensive manual curation, and data is frequently propa-
gated and synchronized between these databases and
MetaCyc. We therefore expect these sets of examples to
be relatively complete and robust.
YeastCyc is also extensively curated, but since its cura-
tion is not closely synchronized with curation of Meta-
Cyc, we have been more cautious in adding yeast
pathways to the gold standard dataset. The main source
of positive examples for yeast is MetaCyc, which
includes approximately 100 curated yeast pathways. In
addition, we included all pathways from YeastCyc that
were reviewed by a YeastCyc curator and are present in
MetaCyc. A number of pathways in YeastCyc are not
included in MetaCyc. Work is in progress on synchro-
nizing YeastCyc and MetaCyc, and these pathways will
be added to the gold standard as they are imported into
MetaCyc. As negative examples, we included a set of
pathways reported by the YeastCyc curators to have
been deleted from YeastCyc. We also obtained an earlier
version of YeastCyc, and included as negative examples
pathways in the older version of YeastCyc that are no
longer present in YeastCyc but still exist in MetaCyc
(but are not annotated as occurring in yeast).
For MouseCyc, CattleCyc, and SynelCyc, all pathways
present were added to the gold standard as positive
examples. Pathways reported by the MouseCyc and Cat-
tleCyc curators to have been deleted were added as nega-
tives, along with pathways recorded as deleted by the
(relatively new) internal database logging mechanisms of
Pathway Tools. The same was done for SynelCyc,
although we were able to more carefully track pathway
deletions because of our oversight of this process.
Evidence Gathering and the PathoLogic Algorithm
PathoLogic is the state-of-the-art pathway prediction
algorithm included in the Pathway Tools software suite
[3,11]. Broadly, this program accepts as input the anno-
tated genome of an organism, and outputs a database
containing objects representing the genes, proteins,
metabolites, reactions, and pathways of an organism.
The batch mode of PathoLogic is used to construct the
BioCyc database collection [4], currently containing 507
PGDBs.
An important step in metabolic network reconstruc-
tion is reactome inference: deriving associations between
the proteins encoded by the genome and the reactions
catalyzed by those proteins. These associations are the
main source of evidence for the pathway inferences of
both PathoLogic and our newer machine learning-based
algorithms. As such, the quality of the inferred meta-
bolic network is highly dependent on the completeness
and correctness of the genome annotation and on the
reaction associations. Linking of proteins with reactions
is performed by the “enzyme matching” component of
PathoLogic, which uses Enzyme Commission (EC) num-
bers, Gene Ontology (GO) annotations, and protein
function or product names to link proteins in an anno-
tated genome with MetaCyc reactions.
The PathoLogic algorithm selects as candidates for
pathway prediction all pathways in MetaCyc that contain
at least one reaction catalyzed by an enzyme in the target
organism. The algorithm then iterates through the list of
Table 1 Number of positive and negative pathways for
each organism in the gold standard dataset
organism positives negatives total
Escherichia coli K-12 MG1655 235 1035 1270
Arabidopsis thaliana columbia 297 971 1268
Saccharomyces cerevisiae S288c 119 777 896
Synechococcus elongatus PCC 7942 171 778 949
Mus musculus 203 754 957
Bos Taurus 151 119 270
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[3] to decide whether or not to include a pathway in the
new PGDB (that is, to predict the pathway as present in
the organism). At each iteration the evidence for or
against each remaining candidate pathway is recomputed
based on the other remaining pathways. (This approach
can affect rules comparing the evidence for multiple
pathways, such as two variants of a biosynthetic function;
only the variants not yet pruned are considered.)
The algorithm terminates when no more candidate
pathways can be kept or pruned by the rules. If any
undecided candidate pathways remain, PathoLogic errs
on the side of inclusiveness, keeping all the candidates
in the database. In the early development of PathoLogic,
i tw a se x p e c t e dt h a tm o s tn e wP G D B sw o u l db ee x t e n -
sively reviewed by human curators, for whom it would
be easier to remove false positives from the new PGDB
than to comprehensively identify false negatives in
MetaCyc. Although this is still a common use case, a
primary motivation for the current work is to develop
an algorithm in which the tradeoff between false posi-
tives and false negatives can be tuned for either meticu-
lous individual database curation, or for high-
throughput PGDB construction.
Feature Extraction and Processing
On the basis of our past experience with the pathway pre-
diction problem, we enumerated during this project a set
of 123 alternative features that we thought might be rele-
vant to this problem. The PathoLogic algorithm defines a
set of 14 basic features which are combined in its rules for
keeping or deleting pathways. In our research we used
existing PathoLogic features, implemented new variations
of PathoLogic features, and defined many novel features
not used by the existing PathoLogic algorithm. Many of
the features are quite similar to one another. The features
include both categorical (Boolean or multivalued) features
and numeric features. More fully, a feature can be a func-
tion of the pathway as well as the organism in which the
pathway’s presence is being predicted (the target organ-
ism). Some features do not depend on evidence in the tar-
get organism, but are only properties of pathways in the
reference database, MetaCyc. (An example is the biosynth-
esis-pathway feature, which indicates whether a pathway is
classified in MetaCyc as carrying out the biosynthesis of
some compound.) A full description of all features consid-
ered can be found in Section 1 of Additional file 2. We
expect that many of the feature names will be self-explana-
tory, but for concreteness we describe a subset of the fea-
tures used in more detail below. Many features test
whether reactions in pathways are present;t h i si st r u ei f
the reaction is linked to an enzyme in the target database
(DB), or if the reaction is annotated in the reference DB as
occurring spontaneously. A unique reaction occurs in only
one pathway. A unique enzyme catalyzes reactions in only
one pathway. Reaction uniqueness is computed by Patho-
Logic with respect to the current set of candidate path-
ways, which changes throughout the algorithm. (An
enzyme can be nonunique if it either catalyzes a single
reaction that occurs in multiple pathways, or catalyzes
multiple reactions that occur in different pathways. An
enzyme catalyzing multiple reactions all occurring only in
a single pathway is still unique to that pathway.) Since our
algorithms do not currently have the notion of a changing
candidate set, uniqueness is computed with respect to all
MetaCyc pathways.
Many of the 123 features can be grouped into the fol-
lowing broad categories:
￿ Reaction evidence. Features based on the identifi-
cation in the genome annotation of enzymes catalyz-
ing reactions.
￿ Pathway holes. Features based on the pattern of
holes (reactions missing enzymes) in a pathway. Is
the pathway split by holes into several fragments?
Does the pathway have long runs of holes? Does a
biosynthetic pathway end with a hole, or a degrada-
tion pathway begin with one?
￿ Pathway connectivity. Features based on the con-
text of the metabolic network (e.g., how well a path-
way is connected to the rest of the metabolic
network).
￿ Genome context. Features based on the position
of the genes involved in each pathway in the target
genome. For example, are there two reactions in the
pathway whose enzymes are encoded by genes that
are adjacent on the genome?
￿ Pathway variants. Features comparing the evi-
dence for a pathway to alternative pathways (if any)
that accomplish roughly the same biological func-
tion. For example, are the enzymes present in a
pathway V1 a subset of the enzymes for a variant V2?
￿ Taxonomic range. Features based on the curated
taxonomic range of the pathway. The taxonomic
range is defined as the set of organisms in which the
pathway is most likely to be present, and is specified
by the MetaCyc curators.
￿ PathoLogic-derived features. Features used by
PathoLogic but not classified in any of the previous
categories.
￿ Pathway properties. Features computed based on
pathway properties such as the number of reactions,
and type of pathway (biosynthesis, degradation/
detoxification, energy production).
Example features include the following:
￿ some-initial-reactions-present: This feature is
true if some initial reaction of the pathway - a
Dale et al. BMC Bioinformatics 2010, 11:15
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- is present.
￿ taxonomic-range-includes-target: Indicates
whether the expected taxonomic range of the path-
way (annotated by curators in MetaCyc) includes the
target organism; false if the taxonomic range is not
annotated, or if it does not include the target
organism.
￿ best-fraction-reactions-present-in-linear-path:
Computes the fraction of reactions present along
each path from an input compound to an output
compound in the pathway; returns the maximum
such value. If the pathway is linear, this is equivalent
to fraction-reactions-present.
￿ evidence-info-content-norm-all: Some reactions
in metabolic networks participate in several path-
ways while other reactions belong to a single path-
way. The more pathways a reaction participates in,
the weaker is the evidence that an enzyme for that
reaction provides for the presence of any one of
those pathways. Thus, we defined several “informa-
tion content"-based features, as exemplified here.
Let m be the number of reactions in pathway P;l e t
Rpres ={ r1, ..., rk} be the set of reactions present in P.
Let n(ri) be the number of pathways in which reac-
tion ri appears. Then the “(all) normalized evidence
information content” is defined as
11
mn r i rR i
()
∈ ∑
pres
This feature measures how strongly the evidence for
pathway P is specific to P; reactions that are present
in P and appear in few other pathways contribute
greater weight. Normalizing by m downweights path-
ways with several promiscuous reactions, relative to
pathways with unique reactions, but fewer of them
present. Other variations omit the normalizing con-
stant, or normalize by the number of reactions
present.
Feature transformations were applied for use in some
of the predictors. For the naïve Bayes predictors,
numeric features were discretized using the following
method. Each feature was discretized individually by
considering each possible threshold between observed
values of the feature in the training set. For each thresh-
old, the information gain obtained by discretizing at that
threshold is computed, and the threshold maximizing
the information gain is selected. For the k-nearest neigh-
bor predictors, feature values were standardized, sub-
tracting from each feature value the mean value of that
feature and dividing by its standard deviation.
Performance Evaluation
For evaluating the performance of both individual fea-
tures and prediction methods, we employed several
widely used performance measures.
Performance of Boolean features or predictions is
summarized by measures that depend on the number of
true positive, false positive, true negative, and false nega-
tive predictions made. Let these numbers be TP, FP, TN,
and FN.A l s ol e tP = TP + FN be the total number of
positives, N = FP + TN the total number of negatives,
and G = P + N the total number of examples. We com-
puted the following measures:
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used here as a measure of the purity of a collection of
positive and negative examples.
For numeric features or predictions (in particular, pre-
dictions representing an estimated probability that a
pathway is present), we compute the accuracy or F-mea-
sure obtained by optimizing over all possible thresholds
of the feature or prediction value. The sensitivity and spe-
cificity are reported at the threshold that maximizes the
accuracy, and the precision and recall are reported at the
threshold that maximizes the F-measure. An additional
performance measure specific to numeric predictions is
the area under the ROC curve (AUC), where the receiver
operating characteristic (ROC) curve plots sensitivity ver-
sus specificity over the entire range of prediction values.
To obtain unbiased estimates of the expected perfor-
mance of our algorithms on new datasets, we do not
report predictor performance on the entire gold stan-
dard dataset. Rather, we split the gold standard into
training and test sets; we train each predictor (including
feature selection, where appropriate) on the training set
and compute its performance based on its predictions
on the test set. The training/test split is done at random,
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held out for test. Each set of predictor performance
results represents the average performance over 20 ran-
dom training/test splits. The decision to use just 50% of
the dataset for training was justified by learning curve
experiments (see Additional file 2: Table S4, S5 and S6),
in which we varied the fraction of examples used for
training and examined performance on the held-out test
data. We observed that performance increased rapidly
up to approximately 1000 to 1500 examples, after which
it increased only slightly.
Training and Prediction
We evaluated four commonly used prediction algo-
rithms: naïve Bayes, kn e a r e s tn e i g h b o r s , decision trees,
and logistic regression.
The naïve Bayes (NB) predictor is a simplified prob-
abilistic model of the input features and the output to
be predicted. The input features and output are repre-
sented as random variables, and the inputs are assumed
to be conditionally independent given the output. Bayes’
rule is used to compute the posterior probability that
the pathway is present, given the observed input fea-
tures. Let Y be a binary random variable indicating
whether a given pathway is present; let X1,. . . ,Xn be a
collection of features with observed values x1, ..., xn.
Then Bayes’ rule gives us
PY X x X x
PX x X x Y PY
nn
nn
(| , )
(, , | ) ( )
== = =
== = =
−
1
11
11
1
11

 
where P(Y = 1) is the prior probability that a pathway
is present. The prior probability is multiplied by the
likelihood of the observed data, and divided by the nor-
malization factor
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y
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to obtain the posterior probability. In this work, we
assume that all the observed features have been discre-
tized to binary values. To obtain the full probability dis-
tribution P(X1 = x1,. . . ,Xn = xn | Y) would require
estimating an exponential number of parameters. The
naïve Bayes model assumes that the feature variables Xi
are conditionally independent, given the output variable
Y, so that posterior probability simplifies to
PY X x X x
PX x Y PY
nn
ii
i
n
(| , )
(| ) ( )
== = =
== =
−
= ∏
1
11
11
1
1


and
 == = =
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
= = ∏ ∑ PX x Y yPY y ii
i
n
y
(| ) ( )
1 0
1
(3)
Here, the number of parameters is linear in the num-
ber of features n. The parameters are estimated from
the training data using maximum likelihood with
pseudocounts.
The k nearest neighbor (kNN) predictor is an instance-
based prediction method. The “training” phase simply
involves recording the observed input and output data
for the training instances. The predictor is parameter-
ized by a positive integer k and a distance function F.
To predict whether a given pathway is present, we select
the k training instances that are most similar to the
instance being classified; similarity is defined by applying
t h ed i s t a n c ef u n c t i o nF to the vectors of input feature
values. Given the k nearest neighbors, a Boolean predic-
tion is computed by majority vote of their output values.
A numeric prediction can be computed as the fraction
of the k nearest neighbors that are present.
We have omitted the performance results for kNN
predictors, as initial experiments found kNN predictors
to perform significantly worse than the naïve Bayes and
decision tree predictors.
A decision tree (DT) predictor consists of a tree data
structure where each internal node of the tree repre-
sents a test of one of the input features used for predic-
tion, for example, testing whether the value of a
Boolean feature is true, or whether the value of a
numeric feature is less than a threshold value stored at
the node. For each possible outcome of the test, there is
a corresponding subtree. Each leaf node in the tree
stores the numbers of present and absent training
instances that satisfy all the tests between the root node
and that leaf node. The decision tree prediction algo-
rithm involves traversing the tree structure by applying
the node tests to the instance being classified, starting
with the test at the root of the tree, and continuing on
to the subtree selected by the test. When a leaf node is
reached, the counts of training examples at the leaf are
used to make either a Boolean prediction (true if the
majority of training instances at that node are present,
false otherwise) or a numeric prediction (estimating the
probability that the instance is present by the fraction of
training instances at the node that are present).
We used the IND software package [12,13] for con-
structing decision trees and classifying instances using
these trees. Several variation so ft h et r e ec o n s t r u c t i o n
procedure were tried, including the use of different
Dale et al. BMC Bioinformatics 2010, 11:15
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to obtain more accurate probability estimates at leaf
n o d e s .I nt h eR e s u l t s ,w er e p o r to n l yt h eb e s t - p e r f o r m -
ing trees; for both single trees and bagged trees, these
were the trees built using the Bayesian smoothed variant
of the strict minimum message length (SMML) princi-
ple. The SMML training procedure aims to construct
the tree for which the encoding cost of the tree plus the
training data is minimized [14].
Logistic regression (LR) is a linear discriminative pre-
diction method that models the logit of the output
probability as a linear function of the features. Let π = P
(Y =1|X1 = x1, ..., Xn = xn). Then we assume that
log


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1
01 1 −
⎛
⎝
⎜
⎞
⎠
⎟ =+ + + = ⋅ xx nn  x (4)
where b and x are vector forms of the parameters: (b0,
b1, ..., bn) and feature values: (1, x1,. . . ,xn)( t h ee x t r a1
in the feature vector allowing for the intercept para-
meter b0). Solving for π, we have the predicted probabil-
ity that a pathway is present as
  =
+ −⋅
1
1 e x (5)
The maximum likelihood estimates of b are obtained
using the iteratively reweighted least-squares (IRLS)
algorithm ([15], Chapter 13).
Feature Selection
The set of 123 input features described in the section
“Feature Extraction and Processing” includes many
groups of features whose values are highly correlated
with each other. To remove bias from the predictions,
and to obtain a more computationally tractable set of
features, it is necessary to perform feature selection to
remove redundant features.
For decision tree predictors, feature selection is built
into the tree construction methods, in the form of heur-
istics for deciding which feature to split on at each
node, and which nodes to prune after a large tree has
been built.
For naïve Bayes and logistic regression predictors, we
used greedy hill-climbing (HC) search to perform for-
ward selection against either of two information criteria:
the Akaike (AIC) [16] or Bayes (BIC) [17]. Each of these
criterion functions takes the form of a penalized log-
likelihood, where models with greater numbers of para-
meters are penalized more heavily to avoid overfitting.
Ensemble Methods
In addition to using individual predictors, we investi-
gated ensemble methods for prediction. These methods
define procedures for training a collection of several dif-
ferent predictors; the prediction made by the ensemble
is obtained by combining the predictions made by the
members of the ensemble: either by taking a majority
vote (to obtain a Boolean prediction) or by averaging (to
obtain a numeric prediction). The particular ensemble
methods used were bagging [18] and random forests
[19].
In bagging (short for “bootstrap aggregating”), the
training dataset is resampled (given the training dataset
D, a new dataset D’, of the same size as D,i sc o n -
structed by selecting instances from D at random with
replacement) and a predictor is trained on the
resampled dataset. This procedure (resample and train)
is repeated r times, and the resulting set of r predictors
is taken as an ensemble.
In more detail, for the naïve Bayes and logistic regres-
sion predictors, the resampled dataset was used to per-
form feature selection as described in the section
“Feature Selection”, and parameters for the resulting
predictor were also computed from the resampled
dataset.
The random forest method is an extension of bagging
where, in addition to resampling the dataset, an addi-
tional element of randomness is introduced into the
training procedure. For NB and LR models, we simply
selected features at random. For decision trees we used
the method described in [19], where rather than choos-
ing the best of all features when splitting a node in the
tree, we select the best feature from a small random
subset of the features.
Results
Feature Performance
Tables 2, 3, and 4 show the highest-performing Boolean
features, numeric features, and numeric features discre-
tized as described in the section “Feature Extraction and
Processing”. The Boolean and discretized numeric fea-
tures are ranked according to the information gain, and
the numeric features according to the AUC; these mea-
sures are described in the section “Performance Evalua-
tion”. For comparison, Table 5 shows the performance
of the existing PathoLogic algorithm.
Predictor Performance
Table 6 shows the performance of several naïve Bayes
predictors. For the predictors with random features, we
first tested the effect of varying the number of features
r,s t a r t i n gw i t hr = 1, then d1.1re, below the total num-
ber of features, 123. We found that r = 37 optimized
AUC, maximum accuracy, and maximum F-measure
(averaging over three replicates for each value of r). For
random “forests” of naïve Bayes predictors, we varied
the number of components c starting from 1, then
d1.1ce, below 100 (an arbitrary cutoff), keeping the
number of features in each component fixed at r =3 7 .
We saw slight improvement in the performance
Dale et al. BMC Bioinformatics 2010, 11:15
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in Table 6.
For the bagged predictors with feature selection, we
varied the number of components from 1 to 20, and
found optimal performance over this range at approxi-
mately c = 15.
Table 7 shows the performance of several logistic
regression predictors. For the predictors with random
features, we again varied the number r of random fea-
tures. We found rapid improvement in performance up
to approximately r = 30, then slower improvement con-
tinuing to the largest value tested, r = 70. To limit the
computational burden, we used r =5 0f o rt h er a n d o m
features and random forest tests. For the random forest
test, we used c = 8 components, obtained by testing c =
1 to 20. We tested bagged BIC predictors with c =1t o
Table 2 Best-performing Boolean features, ordered by information gain
Feature ACC SN SP FM PR RC IG
has-enzymes 0.821 0.914 0.796 0.681 0.543 0.914 0.188
has-reactions-present 0.797 0.919 0.765 0.655 0.509 0.919 0.173
majority-of-reactions-present 0.872 0.707 0.916 0.699 0.69 0.707 0.165
some-initial-reactions-present 0.84 0.724 0.87 0.654 0.597 0.724 0.138
some-initial-and-final-reactions-present 0.864 0.605 0.933 0.651 0.706 0.605 0.136
mostly-absent-not-unique 0.215 0.163 0.229 0.08 0.053 0.163 0.133
all-initial-reactions-present 0.825 0.747 0.845 0.641 0.561 0.747 0.133
every-reaction-present 0.871 0.508 0.968 0.623 0.807 0.508 0.132
every-reaction-present-or-orphaned 0.871 0.508 0.968 0.623 0.807 0.508 0.132
taxonomic-range-includes-target 0.795 0.813 0.79 0.624 0.506 0.813 0.131
See section “Feature Extraction and Processing” and Section 1 of Additional file 2 for description of features.
Columns 2 through 8 correspond to various performance measures: ACC = accuracy; SN = sensitivity; SP = specificity; FM = F-measure; PR = precision; RC =
recall; IG = information gain.
Table 3 Best-performing numeric features, ordered by AUC
Feature AUC max. ACC SN (max. ACC) SP (max. ACC) max. FM PR (max. FM) RC (max. FM)
fraction-reactions-with-Enzymes 0.902 0.878 0.662 0.935 0.715 0.641 0.807
fraction-reactions-present 0.899 0.879 0.618 0.948 0.699 0.612 0.815
fraction-reactions-present-or-Orphaned 0.899 0.879 0.619 0.948 0.7 0.69 0.709
best-fraction-reactions-present-in-linear-path 0.898 0.879 0.662 0.936 0.703 0.682 0.726
evidence-info-content-norm-all 0.894 0.866 0.638 0.927 0.689 0.617 0.781
enzyme-info-content-norm 0.89 0.855 0.69 0.899 0.69 0.584 0.844
enzyme-info-content-unnorm 0.88 0.847 0.665 0.895 0.683 0.556 0.887
evidence-info-content-unnorm 0.875 0.841 0.526 0.925 0.657 0.511 0.918
num-reactions-with-enzymes 0.873 0.838 0.635 0.892 0.681 0.543 0.914
enzymes-per-reaction 0.871 0.842 0.686 0.883 0.688 0.567 0.875
See section “Feature Extraction and Processing” and Section 1 of Additional file 2 for description of features.
Columns 2 through 8 correspond to various performance measures: AUC = area under the ROC curve; max. ACC = maximum thresholded accuracy; SN (max.
ACC) = sensitivity at maximum-accuracy threshold; SP = specificity at maximum-accuracy threshold; max. FM = maximum thresholded F-measure; PR (max. FM) =
precision at maximum-F-measure threshold; RC (max. FM) = recall at maximum-F-measure threshold.
Table 4 Best-performing discretized numeric features, ordered by information gain
Feature ACC SN SP FM PR RC IG
enzyme-info-content-norm 0.824 0.912 0.801 0.685 0.548 0.912 0.19
enzymes-per-reaction 0.822 0.914 0.798 0.683 0.545 0.914 0.189
fraction-reactions-with-enzymes 0.824 0.91 0.801 0.684 0.548 0.91 0.188
num-reactions-with-enzymes 0.821 0.914 0.796 0.681 0.543 0.914 0.188
num-enzymes 0.821 0.914 0.796 0.681 0.543 0.914 0.188
enzyme-info-content-unnorm 0.821 0.914 0.796 0.681 0.543 0.914 0.188
evidence-info-content-norm-all 0.821 0.893 0.802 0.677 0.545 0.893 0.179
best-fraction-reactions-present-in-linear-path 0.842 0.85 0.84 0.693 0.584 0.85 0.179
fraction-reactions-present 0.83 0.869 0.82 0.682 0.562 0.869 0.176
fraction-reactions-present-or-orphaned 0.852 0.817 0.861 0.698 0.609 0.817 0.176
See section “Feature Extraction and Processing” and Section 1 of Additional table 2 for description of features. See Table 2 for explanation of column headings.
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Page 9 of 1420 and found little variation in performance. We report
the performance of bagged HC-BIC predictors for c =8 .
Table 8 shows the performance of decision tree-based
predictors. For bagging, c = 25 trees were used. For ran-
dom forests, c = 100 trees were used; at each step of
growing the trees, r = 20 randomly selected features
were tested as possible splits.
Table 9 shows the performance of predictors incor-
porating the PathoLogic prediction as a feature. The fol-
lowing models, performing comparably to PathoLogic in
the results shown above, were tested: bagged naïve
Bayes with HC-BIC feature selection; logistic regression
with HC-AIC feature selection; and bagged decision
trees. Allowing the PathoLogic prediction to be used as
a feature does not uniformly improve the performance
of these models, as can be seen in particular for the
naïve Bayes model. However, bagged decision trees
using the PathoLogic prediction feature dominate all
other models in the AUC, maximum accuracy, and
maximum F-measure, achieving a slight improvement
over PathoLogic itself.
Discussion
Our results demonstrate that machine learning methods
perform as well as PathoLogic. Note that the results pre-
sented here do not show a full picture of the perfor-
mance of the ML methods, which provide a tradeoff
between sensitivity and specificity (precision and recall)
by virtue of providing estimates of the probabilities of
pathways being present in an organism, rather than sim-
ply binary present/absent calls. The performance of the
Table 5 Performance of the existing, manually crafted
PathoLogic algorithm for pathway prediction
ACC SN SP FM PR RC IG
0.91 0.793 0.94 0.786 0.779 0.793 0.233
See Table 2 for explanation of column headings.
Table 6 Naïve Bayes performance
Predictor AUC max. ACC SN (max. ACC) SP (max. ACC) max. FM PR (max. FM) RC (max. FM)
all features 0.91 0.883 0.763 0.915 0.736 0.68 0.804
random features (r = 37) 0.916 0.884 0.686 0.935 0.725 0.67 0.792
random forest (r = 37, c = 60) 0.924 0.888 0.709 0.936 0.737 0.693 0.791
HC-BIC feature selection 0.933 0.905 0.787 0.936 0.775 0.757 0.794
HC-AIC feature selection 0.938 0.905 0.78 0.938 0.777 0.759 0.796
bagged HC-BIC (c = 15) 0.945 0.908 0.751 0.949 0.782 0.761 0.805
bagged HC-AIC (c = 15) 0.946 0.909 0.757 0.949 0.78 0.767 0.796
See Table 3 for description of column headings. HC-BIC = hill-climbing on Bayes information criterion; HC-AIC = hill-climbing on Akaike information criterion.
Table 7 Logistic regression performance
Predictor AUC max. ACC SN (max. ACC) SP (max. ACC) max. FM PR (max. FM) RC (max. FM)
random features (r = 50) 0.939 0.902 0.732 0.947 0.768 0.74 0.8
random forest (r = 50, c = 8) 0.946 0.909 0.734 0.955 0.779 0.765 0.796
HC-BIC feature selection 0.948 0.91 0.738 0.956 0.785 0.765 0.808
HC-AIC feature selection 0.949 0.911 0.753 0.953 0.787 0.771 0.804
bagged HC-BIC (c = 8) 0.951 0.912 0.744 0.956 0.786 0.763 0.812
See Table 3 for description of column headings. HC-BIC = hill-climbing on Bayes information criterion; HC-AIC = hill-climbing on Akaike information criterion.
Table 9 Predictor performance using PathoLogic prediction as a feature
Predictor AUC max. ACC SN (max. ACC) SP (max. ACC) max. FM PR (max. FM) RC (max. FM)
NB, bagged HC-BIC (c = 15) 0.936 0.912 0.775 0.948 0.79 0.779 0.801
LR, HC-AIC 0.949 0.913 0.756 0.954 0.789 0.773 0.806
DT, bagged (c = 25) 0.953 0.914 0.763 0.954 0.794 0.782 0.807
Table 8 Decision tree performance
Predictor AUC max. ACC SN (max. ACC) SP (max. ACC) max. FM PR (max. FM) RC (max. FM)
single tree 0.946 0.909 0.714 0.961 0.777 0.755 0.802
bagged (c = 25) 0.953 0.911 0.729 0.961 0.787 0.77 0.808
random forest (r = 20, c = 100) 0.952 0.911 0.736 0.957 0.786 0.758 0.818
See Table 3 for description of column headings.
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PathoLogic prediction itself as an input feature.
Figure 2 and Table 10 illustrate a key advantage of the
ML methods over PathoLogic: the ability to dissect and
display the evidence that led to a pathway being labeled
as present or absent. Figure 2 shows the pathway dia-
gram for E. coli pathway 5-aminoimidazole ribonucleo-
tide biosynthesis II, including the enzymes present for
five of the six reactions in the pathway. Table 10 shows
the pathway’s feature values for ten features selected
(using the HC-AIC method) for inclusion in a naïve
Bayes predictor trained on the entire gold standard.
Also included in the table are the (base-2) log-odds
ratios for the pathway’s feature values in the trained pre-
dictor. These values summarize the evidence contribu-
ted by each feature for or against the pathway’s
presence. Positive scores represent evidence in favor of a
pathway’s presence, negative scores against. For
Figure 2 Escherichia coli K-12 MG1655 pathway 5-aminoimidazole ribonucleotide biosynthesis II. This pathway is present in E. coli;
PathoLogic excludes it while our machine learning methods consistently predict it to be present. See Table 10 for selected feature values for
this pathway.
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w o u l db eo b t a i n e di ft h a tf e a t u r ev a l u ew e r et w i c ea s
l i k e l yt ob es e e nf o rap r e s e n tp a t h w a ya sf o rap a t h w a y
that is absent (in the training dataset). In this case, the
features enzyme-info-content-norm and taxonomic-
range-includes-target-alt co n t r i b u t ef a i r l ys t r o n ge v i -
dence for the pathway’s presence, while a handful of the
other features contribute weaker evidence either for or
against the pathway’s presence. A previous study [3]
included a small-scale evaluation of the PathoLogic algo-
rithm on Helicobacter pylori. The current work repre-
sents a major step forward in evaluating pathway
prediction algorithms because we use a much larger
gold standard dataset containing pathways from phylo-
genetically diverse organisms. To find ways to improve
our algorithms, we examined incorrect pathway classifi-
cations made by either PathoLogic alone, by ML-based
methods alone, or by both PathoLogic and the ML-
based methods. We compared the predictions of Patho-
Logic to those of bagged decision trees on gold standard
pathways from E. coli and S. elongatus.
The main cause of false negative classifications (not
predicting to be present pathways that do occur in the
organism) was inability of the enzyme matcher compo-
nent of Pathway Tools (which is shared by PathoLogic
and the ML methods) to find enzymes catalyzing some
reactions in the pathway. In some cases, this failure can
be attributed to incompleteness in the genome annota-
tion. For example, many enzymes lack EC number
annotations. Other enzymes have product names refer-
ring to several reactions; our enzyme name matcher cur-
rently ignores these names. Even for E. coli,w h e r et h e
annotation in EcoCyc is of high quality, our enzyme
matching software cannot recover all enzyme/reaction
matches, so that some evidence for pathway presence is
missed. Issues with enzyme matching also contribute
significantly to false positive predictions. GO function
terms and EC numbers often refer to multiple MetaCyc
reactions, which may participate in different pathways.
This inability to distinguish which of several reactions
an enzyme catalyzes inflates the evidence for some path-
ways. These observations suggest that an important
direction for further improvement of the pathway pre-
diction methods described here lies in improving the
accuracy of enzyme/reaction mapping. Directions for
this work might include extending genome annotation
inputs to include confidence scores from upstream
annotation methods. Data from sequence similarity or
profile HMM search could also be incorporated into the
pathway prediction process, using methods similar to
those used in the Pathway Hole Filler component of
Pathway Tools [5].
Another factor contributing to prediction errors is the
existence of promiscuous reactions. The problem of pro-
miscuous reactions can be addressed in part by making
use of features involving the taxonomic range of a path-
way and its key reactions. Most pathways in MetaCyc
are annotated with an expected taxonomic range; if
pathways sharing reactions have disjoint taxonomic
ranges, this can help distinguish which pathway should
appear in a given organism. PathoLogic enforces taxo-
nomic range constraints rather strictly, by pruning path-
ways that are outside their expected taxonomic range,
except those in which all reactions are present. We
found that taxonomic range features were selected very
frequently by our predictors; in decision trees, these fea-
tures typically appeared very close to the root of the
tree. (see Additional file 2: Table S1, S2 and S3 for lists
of the features selected most frequently by our predic-
tors. Figure 1 in Additionalfile 2 shows an example deci-
sion tree.) However, it appears that our predictors do
not penalize as strongly as PathoLogic pathways that are
outside their taxonomic range.
Key reactions are those reactions in a pathway for
which the lack of enzyme is considered a very strong
indication that the pathway does not occur in the organ-
ism. Key reaction features are frequently selected by our
predictors. However, their current effect on pathway
predictions is limited, because only 103 pathways in
MetaCyc are currently annotated with key reactions
(and thus, our training algorithms will assign little
weight to these features). This will improve as we curate
more key reaction data into MetaCyc.
Related Work
The SEED [20,21] projects subsystems (which include
metabolic pathways) into genomes. An algorithm infers
proposed subsystems, which are checked and refined by
curators. The inference algorithm has not been pub-
lished, nor has its accuracy been measured. A related
research algorithm is described [22]. Reactome [23] per-
forms prediction of metabolic pathways based on
Table 10 Feature values and log-odds ratios for a naïve
Bayes predictor constructed with HC-AIC feature
selection and trained on the entire gold standard, for
pathway 5-aminoimidazole ribonucleotide biosynthesis II,
shown in Figure 2.
Feature Value Log-odds
num-reactions 6 -0.04
enzyme-info-content-norm 0.47 2.19
is-subpathway true 0.67
biosynthesis-pathway true 0.22
majority-of-reactions-present-unique false -0.36
has-key-reactions false -0.07
some-key-reactions-are-present-alt true 0.04
all-key-reactions-are-present-alt true 0.04
taxonomic-range-includes-target-alt true 1.71
subset-has-same-evidence true -0.44
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a description of their algorithm nor an evaluation of its
accuracy. KEGG [24] projects “pathway maps” based on
genome information. KEGG pathway maps encompass
multiple metabolic pathways from multiple organisms
[25]; therefore, KEGG faces the pathway map prediction
problem rather than the pathway prediction problem.
We have been unable to find a description of KEGG’s
algorithm for map prediction or an evaluation of its
accuracy. Methods for constructing flux-balance models
usually predict the metabolic reaction network, but do
not predict metabolic pathways [26].
Large-scale metabolic reconstructions at the pathway
level have been used to perform phylogenetic recon-
struction [27] and to associate metabolic pathways with
phenotypes [28,29]. These efforts have typically used
simple rules or scores for assessing the presence or
absence of pathways. Liao et al. [27] required all reac-
tions in a pathway to have enzymes in order for the
pathway to be considered present. Kastenmüller et al.
[28,29] developed a score similar to the “information
content” features used in our predictors, computing the
fraction of reactions present in the pathway, weighted
according to the uniqueness of the reaction. We expect
that such analyses could be improved by using the prob-
abilities of pathway presence computed by our methods.
Several groups have developed methods for the reac-
tome prediction problem; these methods include Iden-
tiCS [30], metaSHARK [31], and Pathway Analyst
[32,33], which use various sequence analysis techniques
to assign enzymes to the reactions they catalyze. Pub-
lished descriptions of IdentiCS and metaSHARK do not
discuss how enzyme/reaction mappings are use to judge
the presence or absence of pathways in an organism.
Pathway Analyst considersap a t h w a yp r e s e n ti fa n d
only if at least one reaction in the pathway has an
enzyme. While such a rule may be acceptable for small-
scale predictions (as described [33], Pathway Analyst
includes only 10 pathway models, each encompassing
several organism-specific variations of a high-level func-
tion such as “Alanine and aspartate metabolism” or
“Glycolysis/gluconeogenesis”), it will not have sufficient
accuracy for building hundreds of PGDBs from a large
reference pathway database such as MetaCyc.
A number of techniques for discovering (or designing)
novel pathways have been proposed, including search-
based methods (e.g., [34]) which identify plausible paths
between given input and output metabolites. Other
approaches include searching for frequently-occurring
patterns of molecular functions in biological networks
[35] or kernel-based methods for learning associations
between enzymes catalyzing successive functions in
metabolic pathways [36]. These methods provide useful
resources for identifying novel pathways, which are
targets for experimental validation and inclusion in
curated pathway databases such as MetaCyc. In this
respect, pathway discovery methods are a useful comple-
ment to the pathway prediction methods we have
described here.
Conclusions
We have demonstrated the application of machine
learning methods to the problem of metabolic pathway
prediction from an annotated genome. A key product of
this work has been the development of a large “gold
standard” pathway prediction dataset, which we have
used to validate our methods. The development of the
gold standard pathway dataset provides a important
foundation for future work on pathway prediction, by
our group and by others working on this important task.
Our results show that general machine learning meth-
ods, provided with a well-designed collection of input
features, can equal the performance of an algorithm that
h a sb e e nd e v e l o p e da n dr e f i n e do v e ra p p r o x i m a t e l ya
decade. We observed that a small number of features
carry most of the information about whether a pathway
occurs in a target organism. In particular, the fraction of
reactions in the pathway with enzymes was the single
most informative numeric feature. Whether the curated
taxonomic range of the pathway includes the target
organism - a test introduced into PathoLogic since the
previous published description [3] - is also highly infor-
mative. All of the ML predictors we evaluated tended to
include these features. The predictors often also
included other features - newly developed in this work -
which are less informative individually, but can contri-
bute to prediction performance in the context of an
automatically trained ML predictor.
Moreover, the machine learning approach has several
benefits over the older algorithm. The machine learning
approach decomposes the problem into three essential
steps: (1) procuring labeled training data; (2) developing
a modular library of useful features; (3) applying a gen-
eral prediction algorithm. (See Figure 1.) Each of these
steps can be optimized in the future to yield continued
improvements in pathway prediction performance. As
more PGDB curation is performed, the set of available
training data will grow.
New features can easily be implemented and tested in
combination with existing features. New prediction algo-
rithms can be implemented and tested. The machine
learning algorithms we have applied do not simply call
each pathway present or absent, but rather provide an
estimate of the probability that a pathway is present.
Thus, the resulting pathway predictions can be tuned by
the user to suit different preferences for sensitivity ver-
sus specificity. Furthermore, the structure and para-
meters of the model are accessible, and can be used to
Dale et al. BMC Bioinformatics 2010, 11:15
http://www.biomedcentral.com/1471-2105/11/15
Page 13 of 14explain predictions to users of the pathway prediction
software.
Additional file 1: Gold Standard Pathway Dataset. A table containing
the gold standard pathway dataset. Each entry is described by organism
name, NCBI Taxonomy ID, pathway name, pathway ID in the MetaCyc
database, and pathway status ("present” or “absent”). Tab-delimited text
format.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2105-11-
15-S1.TSV]
Additional file 2: Supplementary Material, including additional
tables and figures.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2105-11-
15-S2.PDF]
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